Articles by Control, a senior compliance officer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Control, a senior compliance officer

Of Audits and Gunk

Thanks to their keen observations, these auditors reveal the true culprits of deviations.
Sep 2, 2009

Thanks to their keen observations, these auditors reveal the true culprits of deviations.

Bio Burdens

An ounce of contamination usually leads to a mountain of investigation.
Aug 2, 2009

An ounce of contamination usually leads to a mountain of investigation.

Wasting Away

Some GMP agents seem to find a way to squander time, money, and common sense.
Jul 2, 2009

Some GMP agents seem to find a way to squander time, money, and common sense.

Operator Error

Short-term problems in software or hardware lead to long-term manufacturing troubles.
Jun 2, 2009

Short-term problems in software or hardware lead to long-term manufacturing troubles.

Missing Something?

Process steps, GMP documents, a purification vessel, and validation seem to disappear.
May 2, 2009

Process steps, GMP documents, a purification vessel, and validation seem to disappear.

Out of Control

GMP agents report on old products, aseptic violations, and unexpected emotions.
Apr 2, 2009

GMP agents report on old products, aseptic violations, and unexpected emotions.

Detective Work

The source of a problem reveals itself after some investigation, or it may crash down on you.
Mar 2, 2009

The source of a problem reveals itself after some investigation, or it may crash down on you.

Quick Solutions

GMP experts act fast to resolve some unusual and difficult problems.
Feb 2, 2009

GMP experts act fast to resolve some unusual and difficult problems.

An Ounce of Rejection

Readers give advice on their best approach to handling (batch) rejection
Jan 2, 2009

Readers give advice on their best approach to handling (batch) rejection

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here